LivaNova PLC

NASDAQ:LIVN   4:00:00 PM EDT
55.94
+0.07 (+0.12%)
5:35:52 PM EDT: $55.94 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.02B
Current PE172.01
Forward PE 18.65
2yr Forward PE 16.85
See more stats
Estimates Current Quarter
Revenue$278.18 Million
Adjusted EPS$0.51
See more estimates
10-Day MA$54.64
50-Day MA$52.26
200-Day MA$51.60
See more pivots

LivaNova PLC Stock, NASDAQ:LIVN

20 Eastbourne Terrace, 20 Eastbourne Terrace, London, Greater London W2 6LG
United Kingdom
Phone: +44.203.325.0660
Number of Employees: 2900

Description

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.